Original Research ARTICLE
The Safety of Inhaled CO Therapy in Neonatal Hypoxia-ischemia: A Pilot Study
- 1Pediatrics, University of California, San Francisco, United States
- 2Pediatrics, University of Florida, United States
- 3Agricultural and Biological Egineering, University of Florida, United States
- 4Anesthesiology, University of Florida, United States
- 5Anesthesiology, Neurology, Psychiatry, University of Florida, United States
Objective – The objective of the study was to evaluate the safety of carbon monoxide (CO) as a putative neuroprotective therapy in neonates.
Study Design – Neonatal C57BL/6 mice were exposed to CO at a concentration of either 200 or 250ppm for a period of 1 hour. The pups were then sacrificed at 0, 10, 20, 60, 120, 180, and 240 minutes after exposure to either concentration of CO and blood was collected for analysis of carboxyhemoglobin. Following the safety study, 7 day old pups underwent a unilateral carotid ligation. After recovery, the pups were exposed to a humidified gas mixture of 8% oxygen and 92% nitrogen for 20 minutes in a hypoxia chamber. One hour after the hypoxia exposure, the pups were randomized to one of two groups: air (HI+A) or carbon monoxide (HI+CO). An inhaled dose of 250ppm of CO was administered to the pups for 1 hour a day for a period of 3 days. At 7 days post-injury, the pups were sacrificed and the brains analyzed for cortical and hippocampal volumes.
Results – CO exposure at 200 and 250ppm produced a peak carboxyhemoglobin of 21.52±1.18 and 27.55 ±3.58%, respectively. The carboxyhemoglobin concentrations decreased rapidly reaching control concentrations by 60 minutes post-exposure. At 14 days of age (7 days post injury), the HI+CO (treated with 1 hour per day of 250ppm of CO for 3 days post-injury) had significant preservation of the ratio ipsilateral/contralateral cortex (median 1.07, 25% 0.97, 75% 1.23, n=10) compared the HI+A group (p<0.05).
Conclusion – CO exposure of 250ppm was safe and is effective in preserving cortical volumes following hypoxic-ischemic injury.
Keywords: babies, ischemic stroke, preclinical, Therapeutic gas, Hypoxic Ischemic Encephalopathy
Received: 18 Jan 2018;
Accepted: 13 Apr 2018.
Edited by:Stephane V. Sizonenko, Geneva University Hospitals (HUG), Switzerland
Copyright: © 2018 Douglas-Escobar, Mendes, Rossignol, Bliznyuk, Faraji, Ahmad, Dore and Weiss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: MD. Michael D. Weiss, University of Florida, Pediatrics, 1600 SW Archer Road, Gainesville, 32610, Florida, United States, email@example.com